Geneos Wealth Management’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.13M Buy
25,032
+24,982
+49,964% +$9.37M 0.19% 126
2026
Q1
$14.1K Buy
50
+7
+16% +$2.03K ﹤0.01% 1895
2025
Q4
$12.7K Buy
43
+13
+43% +$3.92K ﹤0.01% 1885
2025
Q3
$7.39K Buy
+30
New +$6.05K ﹤0.01% 2051
2024
Q2
Sell
-457
Closed -$20.5K 2080
2024
Q1
$20.5K Buy
+457
New +$17.3K ﹤0.01% 1352

Other funds holding CLS

Geneos Wealth Management's CLS Position: Q2 2026 in Review

Geneos Wealth Management increased its Celestica (CLS) stake by 49,964% in Q2 2026, buying an estimated $9.37M and bringing the position to 25,032 shares worth $9.13M. The position accounts for 0.19% of the portfolio, ranked #126.

Geneos Wealth Management first reported a position in CLS in Q1 2024 and has held it in 5 quarters since. 875 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Geneos Wealth Management held 25,032 shares of Celestica worth $9.13M as of Q2 2026.
  • Geneos Wealth Management bought 24,982 Celestica shares in Q2 2026, an estimated $9.37M.
  • Celestica made up 0.19% of Geneos Wealth Management's portfolio in Q2 2026, its #126 holding.
  • Geneos Wealth Management first reported a position in Celestica in Q1 2024 and has held it in 5 quarters since.
  • 875 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.